다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

MXCT

MaxCyte (MXCT)

MaxCyte Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MXCT

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/29	21:05	GlobeNewswire Inc.	MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference	NASDAQ:MXCT	MaxCyte Inc
2024/05/22	21:05	GlobeNewswire Inc.	MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development	NASDAQ:MXCT	MaxCyte Inc
2024/05/08	06:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MXCT	MaxCyte Inc
2024/05/08	05:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MXCT	MaxCyte Inc
2024/05/08	05:05	GlobeNewswire Inc.	MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance	NASDAQ:MXCT	MaxCyte Inc
2024/04/10	21:05	GlobeNewswire Inc.	MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024	NASDAQ:MXCT	MaxCyte Inc
2024/04/02	21:05	GlobeNewswire Inc.	MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)	NASDAQ:MXCT	MaxCyte Inc
2024/03/13	05:05	GlobeNewswire Inc.	MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance	NASDAQ:MXCT	MaxCyte Inc
2024/03/06	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MXCT	MaxCyte Inc
2024/03/05	07:39	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MXCT	MaxCyte Inc
2024/03/05	06:05	GlobeNewswire Inc.	MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results	NASDAQ:MXCT	MaxCyte Inc
2024/02/27	06:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MXCT	MaxCyte Inc
2024/02/15	06:26	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MXCT	MaxCyte Inc
2024/02/15	02:25	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:MXCT	MaxCyte Inc
2024/02/09	22:05	GlobeNewswire Inc.	MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences	NASDAQ:MXCT	MaxCyte Inc
2024/02/02	06:25	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MXCT	MaxCyte Inc
2024/01/31	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MXCT	MaxCyte Inc
2024/01/30	22:05	GlobeNewswire Inc.	MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers	NASDAQ:MXCT	MaxCyte Inc
2024/01/27	06:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MXCT	MaxCyte Inc
2024/01/27	01:49	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MXCT	MaxCyte Inc
2024/01/23	22:05	GlobeNewswire Inc.	MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs	NASDAQ:MXCT	MaxCyte Inc
2024/01/09	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MXCT	MaxCyte Inc
2024/01/09	06:05	GlobeNewswire Inc.	MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:MXCT	MaxCyte Inc
2024/01/05	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MXCT	MaxCyte Inc
2024/01/03	22:05	GlobeNewswire Inc.	MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline	NASDAQ:MXCT	MaxCyte Inc
2024/01/02	16:00	GlobeNewswire Inc.	MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director	NASDAQ:MXCT	MaxCyte Inc
2023/12/29	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MXCT	MaxCyte Inc
2023/12/12	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MXCT	MaxCyte Inc
2023/12/12	06:05	GlobeNewswire Inc.	MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023	NASDAQ:MXCT	MaxCyte Inc
2023/12/07	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MXCT	MaxCyte Inc

검색 관련기사 보기:NASDAQ:MXCT

1 2 3 4 5 6 7 다음 >>

American Express

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Verizon Communications

Deutsche Telekom (QX)

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관